Assistant Professor
2921 Stockton Blvd. Suite 1432
Sacramento, CA 95817
Dr. Halmai's research goals are to investigate the role of modulating epigenetic signatures in neurodevelopmental disease; build foundational ‘omics’ datasets and develop novel tools to advance clinical therapies for those currently suffering from untreatable childhood neurological disorders. Technological advancements in epigenome editing has vastly increased our ability to make the undruggable genome druggable. Dr. Halmai's lab focuses on a basic science approach to big data driven design of novel tools for epigenome editors to elucidate the role of chromatin biology in neurodevelopmental disorders.
Neurology
B.Sc., Biotechnology, Van Hall Larenstein, Leeuwarden Netherlands 2012
Ph.D., Integrative Genetics and Genomics, University of California, Davis, Davis CA 2020
M.Sc., Biomedical Sciences, University of Groningen, Groningen Netherlands 2014
Young Investigator Award / Uplifting Athletes and Foundation for ARID1B Research, 2023,
Stem Cell and Gene Therapy Training Program 2.0 Scholar, CIRM, 2023,
Independence Award, International Rett Syndrome Foundation, 2022,
CDKL5 Junior Fellowship Award, CDKL5 Program of Excellence, UPenn Orphan Disease Center, 2019,
Access a full list of Julian Halmai's publications here: https://www.ncbi.nlm.nih.gov/myncbi/julian.halmai.1/bibliography/public/